Differentiating Diabetes mellitus type 2 from other diseases: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 21: Line 21:


{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;"|Disease
! rowspan="2" align="center" style="background:#DCDCDC;"|Disease
! colspan="5" align="center" style="background:#4479BA; color: #FFFFFF;"|History and symptoms
! colspan="5" align="center" style="background:#DCDCDC;"|History and symptoms
! colspan="8" align="center" style="background:#4479BA; color: #FFFFFF;"|Laboratory findings
! colspan="8" align="center" style="background:#DCDCDC;"|Laboratory findings
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;"|Additional findings
! rowspan="2" align="center" style="background:#DCDCDC;"|Additional findings
|-
|-
!align="center" style="background:#4479BA; color: #FFFFFF;"|Polyuria
!align="center" style="background:#DCDCDC;"|[[Polyuria]]
!align="center" style="background:#4479BA; color: #FFFFFF;"|Polydipsia
!align="center" style="background:#DCDCDC;"|[[Polydipsia]]
!align="center" style="background:#4479BA; color: #FFFFFF;"|Polyphagia
!align="center" style="background:#DCDCDC;"|[[Polyphagia]]
!align="center" style="background:#4479BA; color: #FFFFFF;"|Weight loss
!align="center" style="background:#DCDCDC;"|[[Weight loss]]
!align="center" style="background:#4479BA; color: #FFFFFF;"|Weight gain
!align="center" style="background:#DCDCDC;"|[[Weight gain]]
!align="center" style="background:#4479BA; color: #FFFFFF;"|Serum glucose
!align="center" style="background:#DCDCDC;"|[[Serum glucose]]
!align="center" style="background:#4479BA; color: #FFFFFF;"|Urinary Glucose
!align="center" style="background:#DCDCDC;"|Urinary Glucose
!align="center" style="background:#4479BA; color: #FFFFFF;"|Urine PH
!align="center" style="background:#DCDCDC;"|Urine PH
!align="center" style="background:#4479BA; color: #FFFFFF;"|Serum Sodium
!align="center" style="background:#DCDCDC;"|[[Sodium|Serum Sodium]]
!align="center" style="background:#4479BA; color: #FFFFFF;"|Urinary Glucose
!align="center" style="background:#DCDCDC;"|Urinary Glucose
!align="center" style="background:#4479BA; color: #FFFFFF;"|24 hrs cortisol level
!align="center" style="background:#DCDCDC;"|24 hrs [[cortisol]] level
!align="center" style="background:#4479BA; color: #FFFFFF;"|C-peptide level
!align="center" style="background:#DCDCDC;"|[[C-peptide]] level
!align="center" style="background:#4479BA; color: #FFFFFF;"|Serum glucagon
!align="center" style="background:#DCDCDC;"|Serum [[glucagon]]
|-
|-
|style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diabetes mellitus type 1|Type 1 Diabetes mellitus]]
|style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diabetes mellitus type 1|Type 1 Diabetes mellitus]]
Line 150: Line 150:
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/'''↑'''
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/'''↑'''
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/'''↑'''
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/'''↑'''
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Acanthosis nigricans|Acanthosis nigricans,]]  
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Acanthosis nigricans|Acanthosis nigricans]]  
|-
|-
|style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[RTA|RTA 1]]
|style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[RTA|RTA 1]]
Line 200: Line 200:
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Moon face]], [[obesity]], [[buffalo hump]], easy [[Bruising|bruisibility]]
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Moon face]], [[obesity]], [[buffalo hump]], easy [[Bruising|bruisibility]]
|}
|}


==References==
==References==

Revision as of 21:12, 8 March 2017

Diabetes mellitus main page

Diabetes mellitus type 2 Microchapters

Home

Patient information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Diabetes Mellitus Type 2 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical therapy

Life Style Modification
Pharmacotherapy
Glycemic Control

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Differentiating Diabetes Mellitus Type 2 from other Diseases

Differential diagnosis of type 2 DM, include: [1][2][3]

Disease History and symptoms Laboratory findings Additional findings
Polyuria Polydipsia Polyphagia Weight loss Weight gain Serum glucose Urinary Glucose Urine PH Serum Sodium Urinary Glucose 24 hrs cortisol level C-peptide level Serum glucagon
Type 1 Diabetes mellitus - Normal Normal N/ Normal Normal Auto antibodies present (Anti GAD-65 and anti insulin anti bodies)
Type 2 Diabetes mellitus - Normal Normal Normal Normal Acanthosis nigricans
MODY - Normal Normal Normal Normal N -
Psychogenic polydipsia - - - Normal Normal Normal Normal Normal Normal Normal -
Diabetes insipidus - - - Normal Normal Normal Normal Normal Normal Normal -
Transient hyperglycemia - - - - - Normal Normal Normal Normal N/ In hospitalized patients especially in ICU and CCU
Steroid therapy - - - Normal Normal N/ N/ Acanthosis nigricans
RTA 1 - - - - Normal Normal Normal Normal Normal Normal Hypokalemia, nephrolithiasis
Glucagonoma - - - - - Normal Normal Normal - Normal Normal Necrolytic migratory erythema
Cushing syndrome - - - - - Normal N/ Normal Normal Moon face, obesity, buffalo hump, easy bruisibility


References

  1. Barrett TG (2007). "Differential diagnosis of type 1 diabetes: which genetic syndromes need to be considered?". Pediatr Diabetes. 8 Suppl 6: 15–23. doi:10.1111/j.1399-5448.2007.00278.x. PMID 17727381.
  2. Type 1 Diabetes mellitus "Dennis Kasper, Anthony Fauci, Stephen Hauser, Dan Longo, J. Larry Jameson, Joseph Loscalzo"Harrison's Principles of Internal Medicine, 19e Accessed on December 27th,2016
  3. "namrata".

Template:WH Template:WS